Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...
Please provide your email address to receive an email when new articles are posted on . An AI model showed tumor size to be an independent risk factor for prostate cancer metastasis and recurrence. AI ...
Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...
A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...
PSMA-PET quantification required labor-intensive semiautomated software not in routine use. The study enrolled a high-risk metastatic castration-resistant prostate cancer subgroup, limiting ...
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine. The results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback